Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP

SBS · B3

$6.40+$0.13 (+2.07%)TodayMarket closed ·
Prev close $6.27

About SBS

Companhia de Saneamento Basico do Estado de Sao Paulo SABESP engages in the provision of water and sewage service. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 9,204 full-time employees. The company went IPO on 2007-06-04. The firm provides water and sewage services to a range of residential, commercial, industrial and governmental customers in over 375 municipalities in the state of Sao Paulo, including the city of Sao Paulo. The firm's segments include Water and Sewage. The firm's activities comprise water supply, sanitary sewage services, urban rainwater management and drainage services, urban cleaning services, solid waste management services and related activities, including the planning, operation, maintenance and commercialization of energy, and the commercialization of services, products, benefits and rights that directly or indirectly arise from its assets, operations and activities.

Employees
9,204
Headquarters
Sao Paulo, Sao Paulo
Listed
Jun 4, 2007
Sector
Utilities
Industry
Water Utilities

SBS key statistics

Market cap
112.08B
Price-earnings ratio
16.59
Dividend yield
1.51%
Average volume
10.80M
Volume
10.48M
Open price
$6.36
High today
$6.43
Low today
$6.23
52 Week high
$7.16
52 Week low
$4.45

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) at a glance

As of Oct 23, 2026, Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP (SBS) shares are priced at $6.40, giving the company a market cap of 112.08B, a price-to-earnings ratio of 16.59 and a dividend yield of 1.51%.

Today the stock has traded between $6.23 and $6.43. The current price is 2.8% above the day's low and 0.5% below its high.

Volume so far is 10.48M shares, in line with the average of 10.80M shares a day.

Over the past year Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP has ranged from $4.45 to $7.16, and now sits 72% of the way up that range.

Companhia de Saneamento Basico do Estado de Sao Paulo - SABESP met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $0.41 per share against an estimate of $0.4439.

The average analyst price target is $6.66, 4.1% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 13 analystsAvg $6.66
Low
$4.04
Now
$6.40
High
$7.87

SBS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 107.5% on average.

  1. Q3 FY24: reported $1.73 per share against an estimate of $0.3386
  2. Q4 FY24: reported $0.4071 per share against an estimate of $0.505
  3. Q1 FY25: reported $0.4208 per share against an estimate of $0.3979
  4. Q2 FY25: reported $0.6051 per share against an estimate of $0.3365
  5. Q3 FY25: reported $0.6128 per share against an estimate of $0.3351
  6. Q4 FY25: reported $0.8571 per share against an estimate of $0.5242
  7. Q1 FY26: reported $0.50 per share against an estimate of $0.4954
  8. Q2 FY26: reported $0.41 per share against an estimate of $0.4439

SBS news

  • Piero Cingari

    Brazilian Stocks Rally 14%, Eye Best Day Since 2020 After Bolsonaro's First-Round Victory

  • Earnings Preview: Companhia De Saneamento

  • Lekha Gupta

    Reddit, Grab And Autodesk Are Among Top 11 Large-Cap Losers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.